BGLC vs MLM · rev $9.5M vs P/E 36, rev $6.15B
BioNexus Gene Lab Corp Common stock (BGLC) versus Martin Marietta Materials Inc (MLM) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Martin Marietta Materials Inc (MLM) is a building materials company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported MLM revenue for 2025-12-31 was $6.15B. Net income was $1.14B. Revenue was down 5.9% from 2024-12-31 to 2025-12-31. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
BGLC currently screens at market cap $6.1M. MLM currently screens at market cap $34.63B and trailing P/E 36.2.
Not investment advice. Open the BGLC and MLM stock pages for the full models.
Not investment advice.